| Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients E Baudin, CD Cao, AF Cailleux, S Leboulleux, JP Travagli, ... The Journal of Clinical Endocrinology & Metabolism 88 (3), 1107-1111, 2003 | 369 | 2003 |
| A germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors IT Yeh, RE Lenci, Y Qin, K Buddavarapu, AH Ligon, E Leteurtre, CD Cao, ... Human genetics 124, 279-285, 2008 | 183 | 2008 |
| Merits and pitfalls of mifepristone in Cushing's syndrome F Castinetti, M Fassnacht, S Johanssen, M Terzolo, P Bouchard, ... European Journal of Endocrinology 160 (6), 1003-1010, 2009 | 171 | 2009 |
| Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study S Hescot, M Curras-Freixes, T Deutschbein, A van Berkel, D Vezzosi, ... The Journal of Clinical Endocrinology & Metabolism 104 (6), 2367-2374, 2019 | 142 | 2019 |
| Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking M d'Herbomez, P Caron, C Bauters, C Do Cao, JL Schlienger, R Sapin, ... European journal of endocrinology 157 (6), 749-755, 2007 | 140 | 2007 |
| Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach G Donatini, R Caiazzo, C Do Cao, S Aubert, C Zerrweck, Z El-Kathib, ... Annals of surgical oncology 21, 284-291, 2014 | 135 | 2014 |
| French Endocrine Society Guidance on endocrine side effects of immunotherapy F Castinetti, F Albarel, F Archambeaud, J Bertherat, B Bouillet, P Buffier, ... Endocrine-Related Cancer 26 (2), G1-G18, 2019 | 132 | 2019 |
| Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label … P Ferolla, MP Brizzi, T Meyer, W Mansoor, J Mazieres, C Do Cao, H Léna, ... The Lancet Oncology 18 (12), 1652-1664, 2017 | 128 | 2017 |
| Thyroidectomy without radioiodine in patients with low-risk thyroid cancer S Leboulleux, C Bournaud, CN Chougnet, S Zerdoud, A Al Ghuzlan, ... New England Journal of Medicine 386 (10), 923-932, 2022 | 126 | 2022 |
| Digestive neuroendocrine neoplasms (NEN): French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR … L De Mestier, C Lepage, E Baudin, R Coriat, F Courbon, A Couvelard, ... Digestive and Liver Disease 52 (5), 473-492, 2020 | 113 | 2020 |
| A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU … A Ravaud, C de la Fouchardière, P Caron, A Doussau, C Do Cao, ... European Journal of Cancer 76, 110-117, 2017 | 110 | 2017 |
| One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma S Hescot, S Leboulleux, L Amar, D Vezzosi, I Borget, C Bournaud-Salinas, ... The Journal of Clinical Endocrinology & Metabolism 98 (10), 4006-4012, 2013 | 110 | 2013 |
| Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network MH Massicotte, M Brassard, M Claude-Desroches, I Borget, F Bonichon, ... European journal of endocrinology 170 (4), 575-582, 2014 | 109 | 2014 |
| Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases B Bonhomme, Y Godbert, G Perot, A Al Ghuzlan, S Bardet, G Belleannée, ... Thyroid 27 (5), 682-692, 2017 | 98 | 2017 |
| Molecular screening for a personalized treatment approach in advanced adrenocortical cancer MC De Martino, A Al Ghuzlan, S Aubert, G Assié, JY Scoazec, ... The Journal of Clinical Endocrinology & Metabolism 98 (10), 4080-4088, 2013 | 83 | 2013 |
| Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a national study from the French Group of Endocrine Tumors (GTE) B Rault-Petit, C Do Cao, S Guyétant, R Guimbaud, V Rohmer, C Julié, ... Annals of surgery 270 (1), 165-171, 2019 | 81 | 2019 |
| Poorly differentiated thyroid carcinomas: application of the T urin proposal provides prognostic results similar to those from the assessment of high‐grade features V Gnemmi, F Renaud, C Do Cao, J Salleron, G Lion, JL Wemeau, ... Histopathology 64 (2), 263-273, 2014 | 78 | 2014 |
| Malignant insulinoma: recommendations for characterisation and treatment E Baudin, P Caron, C Lombard-Bohas, A Tabarin, E Mitry, Y Reznick, ... Ann Endocrinol (Paris) 74 (5-6), 523-533, 2013 | 66 | 2013 |
| Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU A Ravaud, C Fouchardière, J Asselineau, JP Delord, C Do Cao, P Niccoli, ... The oncologist 15 (2), 212-213, 2010 | 65 | 2010 |
| Anaplastic thyroid carcinoma: an update A Jannin, A Escande, A Al Ghuzlan, P Blanchard, D Hartl, B Chevalier, ... Cancers 14 (4), 1061, 2022 | 63 | 2022 |
